In A549R lung cancer cells, the combined antitumor activity of apigenin and cisplatin was abrogated by the introduction of the p53 inhibitor Pifithrin-α or siRNA-mediated silencing of the p53 gene, indicating a role of p53 in suppressing cancer stem cells [75]. Here, TP53 is linked to lung carcinoma.